Literature DB >> 19909775

TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.

Misato Kikuchi1, Fumihiko Okumura, Tadasuke Tsukiyama, Masashi Watanabe, Naoto Miyajima, Junji Tanaka, Masahiro Imamura, Shigetsugu Hatakeyama.   

Abstract

The androgen receptor (AR) is a ligand-dependent transcription factor that belongs to the family of nuclear receptors, and its activity is regulated by numerous AR coregulators. AR plays an important role in prostate development and cancer. In this study, we found that TRIM24/transcriptional intermediary factor 1alpha (TIF1alpha), which is known as a ligand-dependent nuclear receptor co-regulator, interacts with AR and enhances transcriptional activity of AR by dihydrotestosterone in prostate cancer cells. We showed that TRIM24 functionally interacts with TIP60, which acts as a coactivator of AR and synergizes with TIP60 in the transactivation of AR. We also showed that TRIM24 binds to bromodomain containing 7 (BRD7), which can negatively regulate cell proliferation and growth. A luciferase assay indicated that BRD7 represses the AR transactivation activity upregulated by TRIM24. These findings indicate that TRIM24 regulates AR-mediated transcription in collaboration with TIP60 and BRD7.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909775     DOI: 10.1016/j.bbamcr.2009.11.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network.

Authors:  Ke Xu; Wei Xiong; Ming Zhou; Heran Wang; Jing Yang; Xiayu Li; Pan Chen; Qianjin Liao; Hao Deng; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng
Journal:  Mol Cell Biochem       Date:  2015-09-25       Impact factor: 3.396

2.  Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.

Authors:  Li Ma; Lili Yuan; Jing An; Michelle C Barton; Qingyuan Zhang; Zhaoliang Liu
Journal:  Tumour Biol       Date:  2016-09-16

3.  Assessment of histone tail modifications and transcriptional profiling during colon cancer progression reveals a global decrease in H3K4me3 activity.

Authors:  Karen Triff; Mathew W McLean; Kranti Konganti; Jiahui Pang; Evelyn Callaway; Beiyan Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-16       Impact factor: 5.187

4.  Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

Authors:  Kaishun Hu; Wenjing Wu; Yu Li; Lehang Lin; Dong Chen; Haiyan Yan; Xing Xiao; Hengxing Chen; Zhen Chen; Yin Zhang; Shuangbing Xu; Yabin Guo; H Phillip Koeffler; Erwei Song; Dong Yin
Journal:  EMBO Rep       Date:  2019-04-02       Impact factor: 8.807

5.  Nuclear translocation of p19INK4d in response to oxidative DNA damage promotes chromatin relaxation.

Authors:  Silvina V Sonzogni; María F Ogara; Daniela S Castillo; Pablo F Sirkin; J Pablo Radicella; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2014-09-10       Impact factor: 3.396

6.  Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.

Authors:  Srikanth Appikonda; Kaushik N Thakkar; Parantu K Shah; Sharon Y R Dent; Jannik N Andersen; Michelle C Barton
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

Review 7.  BRD7: a novel tumor suppressor gene in different cancers.

Authors:  Xin Yu; Zheng Li; Jianxiong Shen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

8.  TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Authors:  Anna C Groner; Laura Cato; Jonas de Tribolet-Hardy; Tiziano Bernasocchi; Hana Janouskova; Diana Melchers; René Houtman; Andrew C B Cato; Patrick Tschopp; Lei Gu; Andrea Corsinotti; Qing Zhong; Christian Fankhauser; Christine Fritz; Cédric Poyet; Ulrich Wagner; Tiannan Guo; Ruedi Aebersold; Levi A Garraway; Peter J Wild; Jean-Philippe Theurillat; Myles Brown
Journal:  Cancer Cell       Date:  2016-05-26       Impact factor: 31.743

9.  Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Authors:  Jean-Philippe P Theurillat; Namrata D Udeshi; Wesley J Errington; Tanya Svinkina; Sylvan C Baca; Marius Pop; Peter J Wild; Mirjam Blattner; Anna C Groner; Mark A Rubin; Holger Moch; Gilbert G Prive; Steven A Carr; Levi A Garraway
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

10.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.